PR-Section 8 and 9

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1963 (Rev 05/2006)

OMB No. 0651-0055 (Exp 07/31/2018)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1963 (Rev 05/2006)

OMB No. 0651-0055 (Exp 07/31/2018)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2076469
REGISTRATION DATE: 07/01/1997

MARK: (Stylized and/or with Design, TUMS (see, mark))

The owner, GLAXOSMITHKLINE CONSUMER HEALTHCARE (US) IP LLC, PRIVATE LIMITED LIABILITY COMPANY legally organized under the laws of Delaware, having an address of
      2711 CENTERVILLE ROAD, SUITE 400
      CORPORATION SERVICE COMPANY
      WILMINGTON, Delaware 19808
      United States
      XXXX (authorized)
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: antacids and calcium supplements ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) digital image of the mark depicted on product packaging.
Specimen File1
The registrant's current Attorney Information: Terence A. Dixon of  GLAXOSMITHKLINE
      LGTM - NY0300
      5 CRESCENT DRIVE
      PHILADELPHIA, Pennsylvania 19112
      United States
The phone number is 215.751.7653.
The fax number is 215.751.7051.
The email address is trademarks@gsk.com. (authorized)

The registrant's proposed Attorney Information: Terence A. Dixon of  GSK
      LGTM - NY0300
      5 CRESCENT DRIVE
      PHILADELPHIA, Pennsylvania 19112
      United States The docket/reference number is 81238948/MAS.
The Other Appointed Attorney(s): Charles M. Atkinson, Christopher M. Hanes and Angela L. Wilson.

The phone number is 215.751.7653.
The fax number is 215.751.7051.
The email address is trademarks@gsk.com. (authorized)
The registrant's current Correspondence Information: Terence A. Dixon of  GLAXOSMITHKLINE
      LGTM - NY0300
      5 CRESCENT DRIVE
      PHILADELPHIA, Pennsylvania 19112
      United States
The phone number is 215.751.7653.
The fax number is 215.751.7051.
The email address is trademarks@gsk.com. (authorized)

The registrant's proposed Correspondence Information: Terence A. Dixon of  GSK
      LGTM - NY0300
      5 CRESCENT DRIVE
      PHILADELPHIA, Pennsylvania 19112
      United States The docket/reference number is 81238948/MAS.

The phone number is 215.751.7653.
The fax number is 215.751.7051.
The email address is trademarks@gsk.com. (authorized)

A fee payment in the amount of $425 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.


Declaration

	Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services or to indicate membership in the collective membership organization identified above, as evidenced by the attached specimen(s).
	The specimen(s) shows the mark as currently used in commerce on or in connection with the goods/services/collective membership organization.
	The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /tad/    Date: 04/07/2017
Signatory's Name: Terence A. Dixon
Signatory's Position: Trademark Counsel (Member of the bars of Pennsylvania & New York)
Signatory's Phone: 2157517653

Mailing Address (current):
   GLAXOSMITHKLINE
   5 CRESCENT DRIVE
   PHILADELPHIA, Pennsylvania 19112

Mailing Address (proposed):
   GSK
   5 CRESCENT DRIVE
   PHILADELPHIA, Pennsylvania 19112

Serial Number: 75058334
Internet Transmission Date: Mon Apr 10 08:26:03 EDT 2017
TEAS Stamp: USPTO/S08N09-XXX.XX.XX.X-201704100826035
47145-2076469-580d31d676951edb711392b418
3199515bc4eed15836e490b21b8f51db3e71972-
DA-7994-20170407113734289852